Pacific Biosciences of California (PACB) reported preliminary Q1 revenue of $36.9 million, down from $38.8 million a year earlier.
Analysts polled by FactSet expect $33.3 million.
The company said it expects 2025 revenue of between $155 million and $170 million.
Analysts surveyed by FactSet expect $160.9 million.
The company also said it plans to reduce staff and other costs to bring annualized non-GAAP operating expenses $45 million to $50 million below prior guidance of $270 million to $280 million.
Pacific plans to hold its Q1 earnings call on May 8, the company said.
Shares of the company were up more than 14% in recent Wednesday trading.
Price: 1.38, Change: +0.18, Percent Change: +14.58
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.